KBC Group NV »

Alpine Immune Sciences shares owned by KBC Group NV

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by KBC Group NV

Quarter filed Position value Share count Share price at filing
2024-03-31 $44k 1.1k 39.75

More positions owned by KBC Group NV

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Pepsi (PEP)
Qualcomm (QCOM)
Eli Lilly & Co. (LLY)
Applied Materials (AMAT)
Accenture Plc Ireland Shs Class A (ACN)
UnitedHealth (UNH)
Merck & Co (MRK)
Adobe Systems Incorporated (ADBE)

View all positions for KBC Group NV

Top funds holding Alpine Immune Sciences

Decheng Capital
venBio Select Advisor
BlackRock
Frazier Life Sciences Management
T. Rowe Price Associates
State Street Corporation
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
Lynx1 Capital Management
Paradigm Biocapital Advisors
Darwin Global Management
Commodore Capital
Octagon Capital Advisors
Avidity Partners Management

View all funds holding Alpine Immune Sciences